An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment for patients. The new test can detect patients with strains...
Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible for patients with gonorrhoea to be treated with the cheap...
SpeeDx announced signing two new distribution partners, creating comprehensive access for customers to market-leading SpeeDx ResistancePlus® and PlexPCR® tests across Europe. AB ANALITICA will distribute throughout Italy and...
The British Association for Sexual Health and HIV (BASHH) have published new guidelines for the management of gonorrhoea infections with a strong focus on antimicrobial stewardship of last-line antibiotics. The...
Public Health England (PHE) is investigating two cases of extensively drug resistant (XDR) gonorrhoea recently diagnosed in the U.K. XDR gonorrhoea exhibits resistance patterns to ceftriaxone and azithromycin, the two antibiotics...
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually transmitted infection (STI) N. gonorrhoeae, and sequences in the gyrA...
Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness and learn more about Mycoplasma genitalium, a sexually transmitted disease...
SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and Switzerland), Vircell (Spain), Diamedica (Estonia, Latvia, and Lithuania) and Biomedica...
Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. ResistancePlus® GC will be the first commercially available molecular test to...
SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG. "This test is an exciting new development that will increase the precision of patient care...